Trulieve (CSE: TRUL) announced that they will be reporting their third quarter financials before the market opens on November 15th.
Analysts have a consensus C$84.53 12-month price target on the company, via a total of 17 analysts, representing an upside of 118%. 5 analysts have strong buy ratings, and the other 12 have buy ratings on the company. The street high comes from Stifel-GMP with an C$135 price target, and the lowest target is a C$54 price target.
14 analysts have revenue estimates for the third quarter. The mean between all 14 is US$221.01 million; this number has been revised slightly down from US$228.46 million at the start of May. The street high is US$2224.40 million while the lowest sits at US$216.15 million.
10 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 65.90%, with this number being revised down from 70.13% at the start of May. Street high is 68% estimate and the lowest sits at 63.50%.
Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$89.35 million, with this number being revised down from US$99.88 million at the start of May. Street high sits at US$97 million EBITDA and the lowest being a US$781.2 million estimate.
Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.